Rani Therapeutics Holdings (RANI) Assets Average (2021 - 2026)

Rani Therapeutics Holdings' Assets Average history runs 6 years deep, the most recent figure standing at $55.2 million for Q1 2026.

• On a quarterly basis, Assets Average rose 81.87% year-over-year to $55.2 million in Q1 2026; TTM through Mar 2026 was $55.2 million, a 81.87% increase from a year earlier, with the FY2025 full-year figure at $47.6 million, up 0.75% from the prior year.
• Assets Average grew to $55.2 million in Q1 2026 per RANI's latest filing, from $34.4 million in the prior quarter.
• Across five years, Assets Average topped out at $119.8 million in Q1 2022 and bottomed at $13.5 million in Q3 2025.
• The 5-year median for Assets Average is $55.7 million (2024), against an average of $65.8 million.
• Across the five-year window, Assets Average plunged 69.02% in 2025 and jumped 81.87% in 2026, its largest moves.
• Year by year, Assets Average stood at $108.1 million in 2022, then slumped by 40.64% to $64.2 million in 2023, then sank by 37.54% to $40.1 million in 2024, then declined by 14.24% to $34.4 million in 2025, then surged by 60.7% to $55.2 million in 2026.
• Per Business Quant, the three latest RANI Assets Average figures stand at $55.2 million (Q1 2026), $34.4 million (Q4 2025), and $13.5 million (Q3 2025).